8-K

Company

Aurinia Pharmaceuticals Inc.

Filed

January 9, 2023

Period of Report

January 6, 2023

Accession Number

0001628280-23-000762

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →